View our #VisceralLeishmaniasis surveyor, an online interactive map that summarises #VL and #PKDL clinical trials across the world. Currently displaying 196 trials from 1980-2022, representing 35,000+ patients.
www.iddo.org/tool/vl-surv...

Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post‐Kala‐Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing Post-kala-azar dermal leishmaniasis (PKDL) involves a high macrophage burden in which the Leishmania parasites reside. Liposomal amphotericin B (LAmB) plays a key role in the treatment of PKDL. The m...

How does treatment for #PKDL affect the #leishmaniasis parasite and the human immune system? We need to know so that we can get the dosing right. Read more here doi.org/10.1002/cpt....

View our #VisceralLeishmaniasis surveyor, an online interactive map that summarises #VL and #PKDL clinical trials across the world. Currently displaying 196 trials from 1980-2022, representing 35,000+ patients.
#ZeroLeish
www.iddo.org/tool/vl-surv...

#ScienceReadForSunday: Addressing research questions in #VisceralLeishmaniasis and #PKDL post-kala-azar dermal leishmaniasis: Potential of reusing data from the Infectious Diseases Data Observatory platform
journals.lww.com/amsr/fulltex...

🚨New paper exploring how IPD can be leveraged to address key research questions on #VisceralLeishmaniasis & #PKDL
More 👉 journals.lww.com/amsr/fulltex...
💡 Use the data for your research www.iddo.org/data-sharing...
@prabindahal.bsky.social @philippe-guerin.bsky.social Dawit Getachew Assefa

Join this Pakistani for some car fun!
Onlyfans.com/nikkabuilder
#chudai #gay #onlyfans #top #pkdl #desigay

View our #VisceralLeishmaniasis surveyor, an online interactive map that summarises #VL and #PKDL clinical trials across the world. Currently displaying 196 trials from 1980-2022, representing 35,000+ patients.
www.iddo.org/tool/vl-surv...

Unsupervised machine learning identifies biomarkers of disease progression in post-kala-azar dermal leishmaniasis in Sudan Author summary Post-kala-azar dermal leishmaniasis (PKDL) is a neglected disease that causes stigmatization and carries a significant socioeconomic and personal burden in South Asia and East Africa. C...

Could machine learning transform #PKDL diagnosis? A new study identifies key patient factors that could improve detection of difficult-to-treat cases in Sudan, paving the way for better diagnosis & treatment. Read more in @plos.org: doi.org/10.1371/jour...

View our #VisceralLeishmaniasis surveyor, an online interactive map that summarises #VL and #PKDL clinical trials across the world. Currently displaying 196 trials from 1980-2022, representing 35,000+ patients.
www.iddo.org/tool/vl...